Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine and Cisplatin with Radiation for Cervical or Vaginal Cancer
NCT00941070Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triapine in Cervical Cancer (CC) and vaginal cancer, sponsored by National Cancer Institute. Primary endpoint: Fasting F-18 Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) Imaging Complete Metabolic Response. Started Jul 2009; status: completed.
02
Drugs
triapine
03
Conditions
Cervical Cancer (CC)vaginal cancer
Beyond the preview
Go deeper on NCT00941070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941070.